Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 148 No. 2930 (2018)

Awareness, approval and completion of advance directives in older adults in Switzerland

  • Sarah Vilpert
  • Carmen Borrat-Besson
  • Jürgen Maurer
  • Gian Domenico Borasio
Cite this as:
Swiss Med Wkly. 2018;148:w14642



Advance directives enable people to describe their preferences for medical treatment (living will) and/or to appoint a healthcare proxy who may decide on their behalf should they lose decision-making capacity. Advance directives are potentially important in determining the course of end-of-life care, as deaths are frequently preceded by end-of-life treatment decisions, which often require someone to make decisions on the patient’s behalf. Switzerland introduced legally binding advance directives through its new child and adult protection law of 2013. But there is still no comprehensive evidence on older persons’ awareness, attitudes and behaviours with regard to advance directives in Switzerland.


Our study aimed to assess levels of awareness, approval and completion of advance directives, as well as their respective associations with sociodemographic characteristics in the Swiss population aged 55 and older. Our study was cross-sectional and used data from the Survey of Health, Ageing and Retirement in Europe (SHARE), which included a special module on end-of-life issues in wave 6 (2015) in Switzerland (n = 2085).


Two years after the introduction of advance directives in Switzerland, 78.7% of adults aged 55 years and older had heard of them prior to the survey and 24% reported that they had completed one. Awareness of advance directives was higher in the German-speaking part of Switzerland (91%) than in the Italian- (57.1%) and French-speaking (43.3%) regions (p <0.001). Advance directive completion also differed significantly between the German- (28.7%), French- (10.3%) and Italian-speaking (17.9%) regions of Switzerland (p <0.001). Overall, 76.7% of Swiss adults aged 55 and older generally approved of advance directives, i.e., they either reported having already completed one or were planning to do so in the future. Of those who had not yet completed an advance directive, 32.9% believed that it was still “too early” for them to do so and 30.1% believed that they would not need one. Levels of awareness, approval and completion of advance directives also varied significantly by sex, age, education level and household composition.


Our results show some potential for improvement in levels of advance directive awareness and, especially, completion among older adults, notably in the French- and Italian-speaking Switzerland. In view of the generally high levels of approval of advance directives, our findings point to important barriers to their completion by older persons that should be addressed by policy makers in order to ensure an effective translation of individual intentions to complete an advance directive sometime in the future into concrete and timely actions toward this end.


  1. Décès. Neuchâtel: Office fédéral de la statistique; 2018 [cited 2018 06.02]; Available from:
  2. Bosshard G, Zellweger U, Bopp M, Schmid M, Hurst SA, Puhan MA, et al. Medical End-of-Life Practices in Switzerland: A Comparison of 2001 and 2013. JAMA Intern Med. 2016;176(4):555–6. doi:.
  3. Reich O, Signorell A, Busato A. Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data. BMC Health Serv Res. 2013;13(1):116. doi:.
  4. Silveira MJ, Kim SY, Langa KM. Advance directives and outcomes of surrogate decision making before death. N Engl J Med. 2010;362(13):1211–8. doi:.
  5. Pautex S, Herrmann FR, Zulian GB. Role of advance directives in palliative care units: a prospective study. Palliat Med. 2008;22(7):835–41. doi:.
  6. van Wijmen MP, Pasman HR, Widdershoven GA, Onwuteaka-Philipsen BD. Motivations, aims and communication around advance directives: a mixed-methods study into the perspective of their owners and the influence of a current illness. Patient Educ Couns. 2014;95(3):393–9. doi:.
  7. Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340(mar23 1):c1345. doi:.
  8. Martin DK, Emanuel LL, Singer PA. Planning for the end of life. Lancet. 2000;356(9242):1672–6. doi:.
  9. Carr D, Luth E. Advance Care Planning: Contemporary Issues and Future Directions. Innovation in Aging. 2017;1(1):igx012. doi:.
  10. Carr D. Death and dying in the contemporary United States: what are the psychological implications of anticipated death? Soc Personal Psychol Compass. 2012;6(2):184–95. doi:.
  11. Des directives anticipées du patient, Art. 370 (2008). Available from:
  12. Directives anticipées – pour plus de sécurité. Fédération des médecins suisses; 2018 [cited 2018 06.02]; Available from:
  13. Dossier pour les directives anticipées. ProSenectute; 2018 [cited 2018 06.02]; Available from:
  14. Etablissez vos directives anticipées avec nous. Croix Rouge Suisse; 2018 [cited 2018 06.02]; Available from:
  15. SHARE. End-of-life questionnaire. Munich: Max Planck Institute for Social Law and Social Policy (MEA); 2018 [cited 2018 14.05.2018]; Available from:
  16. Börsch-Supan A. Survey of Health, Ageing and Retirement in Europe (SHARE) Wave 6. Release version: 6.0.0. In: SHARE-ERIC, editor. 2017.
  17. Klevmarken A, Hesselius P, Swensson P. The SHARE Sampling Procedures and Calibrated Designs Weights In: Börsch-Supan A, Jürges H, editors. The Survey of Health, Ageing and Retirement in Europe – Methodology. Mannheim: Mannheim Research Institute for the Economics of Aging (MEA); 2005. p. 66-9.
  18. Lynn P, De Luca G, Ganninger M, Häder S. Sample Design in SHARE Wave Four. In: Malter F, Börsch-Supan A, editors. SHARE Wave 4: Innovations & Methodology. Munich Munich Center for the Economics of Aging (MEA); 2013. p. 91-3.
  19. SHARE Release Guide 6.0.0. Munich: MEA, Munich Center for the Economics of Aging; 2017.
  20. Solon G, Haider SJ, Wooldridge J. What Are We Weighting For? NBER working paper series. 2013. Available from:
  21. Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012;12(2):308–31.
  22. Andorno R, Biller-Andorno N, Brauer S. Advance health care directives: towards a coordinated European policy? Eur J Health Law. 2009;16(3):207–27. doi:.
  23. Yadav KN, Gabler NB, Cooney E, Kent S, Kim J, Herbst N, et al. Approximately One In Three US Adults Completes Any Type Of Advance Directive For End-Of-Life Care. Health Aff (Millwood). 2017;36(7):1244–51. doi:.
  24. Alano GJ, Pekmezaris R, Tai JY, Hussain MJ, Jeune J, Louis B, et al. Factors influencing older adults to complete advance directives. Palliat Support Care. 2010;8(3):267–75. doi:.
  25. del Pozo Puente K, Hidalgo JL, Herráez MJ, Bravo BN, Rodríguez JO, Guillén VG. Study of the factors influencing the preparation of advance directives. Arch Gerontol Geriatr. 2014;58(1):20–4. doi:.
  26. Rao JK, Anderson LA, Lin FC, Laux JP. Completion of advance directives among U.S. consumers. Am J Prev Med. 2014;46(1):65–70. doi:.
  27. Rurup ML, Onwuteaka-Philipsen BD, van der Heide A, van der Wal G, Deeg DJ. Frequency and determinants of advance directives concerning end-of-life care in The Netherlands. Soc Sci Med. 2006;62(6):1552–63. doi:.
  28. van Wijmen MP, Rurup ML, Pasman HR, Kaspers PJ, Onwuteaka-Philipsen BD. Advance directives in the Netherlands: an empirical contribution to the exploration of a cross-cultural perspective on advance directives. Bioethics. 2010;24(3):118–26. doi:.
  29. Wilson DM, Houttekier D, Kunju SA, Birch S, Cohen J, MacLeod R, et al. A population-based study on advance directive completion and completion intention among citizens of the western Canadian province of Alberta. J Palliat Care. 2013;29(1):5–12.
  30. Colombo F, Llena-Nozal A, Mercier J, Tjadens F. The impact of caring on families carers. In: Studies OHP, editor. Help wanted? Providing and paying for long-term care: OECD Publishing; 2011.
  31. Hopp FP. Preferences for surrogate decision makers, informal communication, and advance directives among community-dwelling elders: results from a national study. Gerontologist. 2000;40(4):449–57. doi:.
  32. Wiesing U, Jox RJ, Hessler HJ, Borasio GD. A new law on advance directives in Germany. J Med Ethics. 2010;36(12):779–83. doi:.
  33. Horn R. “Why Should I Question a Patient’s Wish?” A Comparative Study on Physicians’ Perspectives on Their Duties to Respect Advance Directives. Eur J Health Law. 2017;24(5):523–40. doi:.
  34. Deutlicher Anstieg bei Patientenverfügungen. Allensbach: Institut für Demoskopie Allensbach; 2014. Available from:
  35. Palazzolo J. Les nouvelles relations médecin-malade. Cerveau et Psycho. 1999;30 November. Available from:
  36. LOI n° 2016-87créant de nouveaux droits en faveur des malades et des personnes en fin de vie. 2016. Available from :
  37. C'è l'ok del Senatio, il biotestamento è legge: ecco che cosa prevede. La Stampa. 2017. 14 December. Available from:
  38. Busato A, Künzi B. Primary care physician supply and other key determinants of health care utilisation: the case of Switzerland. BMC Health Serv Res. 2008;8(1):8. doi:.
  39. Luta X, Panczak R, Maessen M, Egger M, Goodman DC, Zwahlen M, et al. Dying among older adults in Switzerland: who dies in hospital, who dies in a nursing home? BMC Palliat Care. 2016;15(1):83. doi:.
  40. Panczak R, Luta X, Maessen M, Stuck AE, Berlin C, Schmidlin K, et al. Regional Variation of Cost of Care in the Last 12 Months of Life in Switzerland: Small-area Analysis Using Insurance Claims Data. Med Care. 2017;55(2):155–63. doi:.
  41. Fischer S, Bosshard G, Faisst K, Tschopp A, Fischer J, Bär W, et al. Swiss doctors’ attitudes towards end-of-life decisions and their determinants: a comparison of three language regions. Swiss Med Wkly. 2006;136(23-24):370–6.
  42. Pautex S, Gamondi C, Philippin Y, Gremaud G, Herrmann F, Camartin C, et al. Advance directives and end-of-life decisions in Switzerland: role of patients, relatives and health professionals. BMJ Support Palliat Care. 2015 2 September:bmjspcare-2014-000730. doi:.
  43. Nolan MT, Bruder M. Patients’ attitudes toward advance directives and end-of-life treatment decisions. Nurs Outlook. 1997;45(5):204–8. doi:.
  44. Otte IC, Jung C, Elger BS, Bally K. Advance directives and the impact of timing. A qualitative study with Swiss general practitioners. Swiss Med Wkly. 2014;144:w14035. doi:.
  45. Silveira MJ, Wiitala W, Piette J. Advance directive completion by elderly Americans: a decade of change. J Am Geriatr Soc. 2014;62(4):706–10. doi:.
  46. Seymour J, Gott M, Bellamy G, Ahmedzai SH, Clark D. Planning for the end of life: the views of older people about advance care statements. Soc Sci Med. 2004;59(1):57–68. doi:.